Malaria transmission-blocking vaccines are in development, but roll-out strategies have not been assessed. Here, the authors show that transmission-blocking activity is likely to be higher in the field than in laboratory conditions, and that school-aged children are an important group to target.
- Joseph D. Challenger
- Daniela Olivera Mesa
- Thomas S. Churcher